Abstract
Antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitides are rare, but they can be triggered by chemicals, infections and drugs; among them, antithyroid drugs are common. Autoimmune disorders, such as vasculitis, are unusual, but serious complications of antithyroid therapy. Both propylthiouracil (PTU) and methimazole may induce ANCA-associated vasculitis. PTU-induced vasculitides may have different organ involvement patterns. Herein, we report four cases with ANCA-associated vasculitis with different clinical manifestations.
Similar content being viewed by others
References
Jennette JC, Falk RC (1997) Small-vessels vasculitis. N Engl J Med 337:1512–1523
Yazisiz V, Öngüt G, Terzioğlu E, Karayalçin Ü (2010) Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment. Int J Clin Pract 64(1):19–24
Cin OM, Gursoy A, Morris Y, Aydıntuğ OT, Kamel N, Gullu S (2009) Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves’ patients treated with propylthiouracil. Int J Clin Pract 63(2):299–302
Reumaux D, Duthilleul P, Roos D (2004) Pathogenesis of diseases associated with antineutrophil cytoplasmic antibodies. Hum Immunol 65:1–12
Savage COS, Harper L, Holland M (2002) New findings in pathogenesis of antineutrophil cytoplasm antibody-associated vasculitis. Curr Opinion in Rheum 14:15–22
Gao Y, Zhao MH (2009) Review article: drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrology 14:33–41
Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M (2005) Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitis. Arhtritis Res Ther 7:1072–1081
Quax RAM, Swaak AJG, Baggen MGA (2009) Churg-Strauss Syndrome following PTU treatment. Int J Rheumatol 2009:504105. Epub 2009 Mar 8
Sato H, Hattori M, Fujieda M, Sugihara S, Inomata H, Hoshi M, Mıyamoto S (2000) High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves’ disease treated with propylthiouracil. J Clin Endoctinol Metab 85:4270–4273
Mathieu E, Fain O, Sitbon M, Thomas M (1999) Systemic adverse effect of antithyroid drugs. Clin Rheumatol 18:66–68
Ozkok A, Salman S, Agan M et al (2009) Propylthiouracil induced anti-neutrophil cytoplasmic antibody-associated vasculitis with bone marrow plasmocytosis and granulocytopenia. Chin Med J 122(9):1112–1114
Pietszkowski NC, Carvalho GA, Souza HN, Werka CR Jr, Borazo LA, Graf H, Carvalho M (2007) Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune disease induced by propylthiouracil. Arq Bras Endocrinol Metabol 51(1):136–141
Guma M, Salinas I, Reverter JL et al (2003) Frequency of antineutrophil cytoplasmic antibody in Graves’ disease patients treated with methimazole. J Clin Endocrinol Metab 88:2141–2146
Yu F, Chen M, Gao Y, Wang S, Zou W, Zhao M, Wang H (2007) Clinical and pathological features of renal involvement in propylthiouracil—associated ANCA—positive vasculitis. Am J Kid Disvol 49(5):607–614
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bilge, N.Ş.Y., Kaşifoğlu, T. & Korkmaz, C. PTU-induced ANCA-positive vasculitis: an innocent or a life-threatening adverse effect?. Rheumatol Int 33, 117–120 (2013). https://doi.org/10.1007/s00296-011-2280-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-011-2280-5